Joseph P Hagan Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

AUPH Quotes by TradingView

Joseph P Hagan is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 11,961 shares of AUPH, which is worth approximately $86,238. The most recent transaction as insider was on May 19, 2023, when has been sold 272 shares (Common Stock) at a price of $10.58 per share, resulting in proceeds of $2,877. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12K
0% 3M change
0% 12M change
Total Value Held $86,238

Joseph P Hagan Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2023
SELL
Open market or private sale
$2,877 $10.58 p/Share
272 Reduced 2.22%
11,961 Common Stock
May 18 2023
BUY
Exercise of conversion of derivative security
-
8,733 Added 41.65%
12,233 Common Stock
Jan 03 2022
SELL
Open market or private sale
$917,600 $22.94 p/Share
40,000 Reduced 91.95%
3,500 Common Stock
Jan 03 2022
BUY
Exercise of conversion of derivative security
$203,200 $5.08 p/Share
40,000 Added 47.9%
43,500 Common Stock

Also insider at

RGLS
Regulus Therapeutics Inc. Healthcare
Chief Executive Officer
ZSANQ
Zosano Pharma Corp
Director
JPH

Joseph P Hagan

Director
Victoria, A1

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AUPH